Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Influenza

  Free Subscription


Articles published in Eur J Epidemiol

Retrieve available abstracts of 83 articles:
HTML format



Single Articles


    June 2024
  1. MEYER AC, Ebeling M, Acosta E, Modig K, et al
    Continued decline in the incidence of myocardial infarction beyond the COVID-19 pandemic: a nationwide study of the Swedish population aged 60 and older during 2015-2022.
    Eur J Epidemiol. 2024;39:605-612.
    PubMed     Abstract available


  2. AUGER N, Arbour L, Lewin A, Brousseau E, et al
    Congenital anomalies during Covid-19: artifact of surveillance or a real TORCH?
    Eur J Epidemiol. 2024;39:613-621.
    PubMed     Abstract available


    March 2024
  3. ROTHMAN KJ
    The public-health mindset : Review of "The public health approach - population thinking from the black death to COVID-19" by Alfredo Morabia, Johns Hopkins University Press, 2023.
    Eur J Epidemiol. 2024;39:323-324.
    PubMed    


    February 2024
  4. YANG L, Chen W, Chen D, He J, et al
    Cohort profile: the China surgery and anesthesia cohort (CSAC).
    Eur J Epidemiol. 2024;39:207-218.
    PubMed     Abstract available


  5. NORSTROM T, Ramstedt M
    The impact of the COVID-19 pandemic on mortality in Sweden-Did it differ across socioeconomic groups?
    Eur J Epidemiol. 2024;39:137-145.
    PubMed     Abstract available


    December 2023
  6. HARRISON EA
    Losing the Public, for Better or for Worse: A Lesson from John Everett Gordon (1890-1983) and John Rodman Paul (1893-1971).
    Eur J Epidemiol. 2023;38:1213-1217.
    PubMed     Abstract available


  7. CHIOLERO A, Tancredi S, Ioannidis JPA
    Slow data public health.
    Eur J Epidemiol. 2023;38:1219-1225.
    PubMed     Abstract available


    November 2023
  8. ANDERSON R
    Measuring mortality arising from the Covid-19 pandemic and the impact of vaccination.
    Eur J Epidemiol. 2023;38:1119-1123.
    PubMed    


  9. JIA KM, Hanage WP, Lipsitch M, Johnson AG, et al
    Estimated preventable COVID-19-associated deaths due to non-vaccination in the United States.
    Eur J Epidemiol. 2023;38:1125-1128.
    PubMed     Abstract available


  10. LEVITT M, Zonta F, Ioannidis JPA
    Excess death estimates from multiverse analysis in 2009-2021.
    Eur J Epidemiol. 2023;38:1129-1139.
    PubMed     Abstract available


  11. ALICANDRO G, La Vecchia C, Islam N, Pizzato M, et al
    A comprehensive analysis of all-cause and cause-specific excess deaths in 30 countries during 2020.
    Eur J Epidemiol. 2023;38:1153-1164.
    PubMed     Abstract available


    August 2023
  12. LIN S, Gao X, Degenhardt F, Qian Y, et al
    Genome-wide epistasis study highlights genetic interactions influencing severity of COVID-19.
    Eur J Epidemiol. 2023;38:883-889.
    PubMed     Abstract available


  13. NORREDAM M, Islamoska S, Petersen JH, Benfield T, et al
    COVID-19 mortality and use of intensive care among ethnic minorities - a national register-based Danish population study.
    Eur J Epidemiol. 2023;38:891-899.
    PubMed     Abstract available


    May 2023
  14. ANDERSEN MP, Mills EHA, Meddis A, Sorensen KK, et al
    All-cause mortality among Danish nursing home residents before and during the COVID-19 pandemic: a nationwide cohort study.
    Eur J Epidemiol. 2023;38:523-531.
    PubMed     Abstract available


    April 2023
  15. BUTTIA C, Llanaj E, Raeisi-Dehkordi H, Kastrati L, et al
    Prognostic models in COVID-19 infection that predict severity: a systematic review.
    Eur J Epidemiol. 2023;38:355-372.
    PubMed     Abstract available


    March 2023
  16. POZO-MARTIN F, Beltran Sanchez MA, Muller SA, Diaconu V, et al
    Comparative effectiveness of contact tracing interventions in the context of the COVID-19 pandemic: a systematic review.
    Eur J Epidemiol. 2023;38:243-266.
    PubMed     Abstract available


  17. BEUKENHORST AL, Koch CM, Hadjichrysanthou C, Alter G, et al
    SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.
    Eur J Epidemiol. 2023;38:237-242.
    PubMed     Abstract available


  18. BELL M, Ekbom A, Linder M
    COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm.
    Eur J Epidemiol. 2023;38:301-311.
    PubMed     Abstract available


    February 2023
  19. BOWYER RCE, Huggins C, Toms R, Shaw RJ, et al
    Characterising patterns of COVID-19 and long COVID symptoms: evidence from nine UK longitudinal studies.
    Eur J Epidemiol. 2023;38:199-210.
    PubMed     Abstract available


    January 2023
  20. RODIAH I, Vanella P, Kuhlmann A, Jaeger VK, et al
    Age-specific contribution of contacts to transmission of SARS-CoV-2 in Germany.
    Eur J Epidemiol. 2023;38:39-58.
    PubMed     Abstract available


  21. ANGELINI M, Teglia F, Astolfi L, Casolari G, et al
    Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis.
    Eur J Epidemiol. 2023;38:31-38.
    PubMed     Abstract available


    December 2022
  22. JOYAL-DESMARAIS K, Stojanovic J, Kennedy EB, Enticott JC, et al
    How well do covariates perform when adjusting for sampling bias in online COVID-19 research? Insights from multiverse analyses.
    Eur J Epidemiol. 2022;37:1233-1250.
    PubMed     Abstract available


    November 2022
  23. SIEURIN J, Branden G, Magnusson C, Hergens MP, et al
    A population-based cohort study of sex and risk of severe outcomes in covid-19.
    Eur J Epidemiol. 2022;37:1159-1169.
    PubMed     Abstract available


    October 2022
  24. SAMUEL A
    Re: Carrat et al. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.
    Eur J Epidemiol. 2022;37:1083-1084.
    PubMed    


  25. BERGHOFER A, Rotter G, Pankert J, Icke K, et al
    SARS-CoV-2 infections in professional orchestra and choir musicians-a prospective cohort study.
    Eur J Epidemiol. 2022;37:1061-1070.
    PubMed     Abstract available


  26. BANHOLZER N, Lison A, Ozcelik D, Stadler T, et al
    The methodologies to assess the effectiveness of non-pharmaceutical interventions during COVID-19: a systematic review.
    Eur J Epidemiol. 2022;37:1003-1024.
    PubMed     Abstract available


  27. MATHIEU C, Pambrun E, Benard-Laribiere A, Noize P, et al
    Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study.
    Eur J Epidemiol. 2022;37:1049-1059.
    PubMed     Abstract available


  28. EBELING M, Acosta E, Caswell H, Meyer AC, et al
    Years of life lost during the Covid-19 pandemic in Sweden considering variation in life expectancy by level of geriatric care.
    Eur J Epidemiol. 2022;37:1025-1034.
    PubMed     Abstract available


  29. BUCYIBARUTA G, Blangiardo M, Konstantinoudis G
    Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study.
    Eur J Epidemiol. 2022;37:1071-1081.
    PubMed     Abstract available


  30. MCDONALD SA, Lagerweij GR, de Boer P, de Melker HE, et al
    The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years.
    Eur J Epidemiol. 2022;37:1035-1047.
    PubMed     Abstract available


    September 2022
  31. IOANNIDIS JPA
    Estimating conditional vaccine effectiveness.
    Eur J Epidemiol. 2022;37:885-890.
    PubMed     Abstract available


  32. JOLLANT F, Blanc-Brisset I, Cellier M, Ambar Akkaoui M, et al
    Temporal trends in calls for suicide attempts to poison control centers in France during the COVID-19 pandemic: a nationwide study.
    Eur J Epidemiol. 2022;37:901-913.
    PubMed     Abstract available


    August 2022
  33. GARCIA-ALBENIZ X, Del Amo J, Polo R, Morales-Asencio JM, et al
    Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19.
    Eur J Epidemiol. 2022;37:789-796.
    PubMed     Abstract available


  34. SCHONS M, Pilgram L, Reese JP, Stecher M, et al
    The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics.
    Eur J Epidemiol. 2022;37:849-870.
    PubMed     Abstract available


  35. GELDSETZER P, Mukama T, Jawad NK, Riffe T, et al
    Sex differences in the mortality rate for coronavirus disease 2019 compared to other causes of death: an analysis of population-wide data from 63 countries.
    Eur J Epidemiol. 2022;37:797-806.
    PubMed     Abstract available


    June 2022
  36. NARRES M, Claessen H, Kvitkina T, Rosenbauer J, et al
    Hospitalisation rate and mortality among people with and without diabetes during the COVID-19 pandemic year 2020.
    Eur J Epidemiol. 2022;37:587-590.
    PubMed     Abstract available


    May 2022
  37. VERBERK JDM, de Hoog MLA, Westerhof I, van Goethem S, et al
    Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries.
    Eur J Epidemiol. 2022;37:549-561.
    PubMed     Abstract available


  38. CASPERSEN IH, Magnus P, Trogstad L
    Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort.
    Eur J Epidemiol. 2022;37:539-548.
    PubMed     Abstract available


    March 2022
  39. LEVIN AT, Jylhava J, Religa D, Shallcross L, et al
    COVID-19 prevalence and mortality in longer-term care facilities.
    Eur J Epidemiol. 2022;37:227-234.
    PubMed     Abstract available


  40. AXFORS C, Ioannidis JPA
    Infection fatality rate of COVID-19 in community-dwelling elderly populations.
    Eur J Epidemiol. 2022;37:235-249.
    PubMed     Abstract available


    February 2022
  41. HERGENS MP, Bell M, Haglund P, Sundstrom J, et al
    Risk factors for COVID-19-related death, hospitalization and intensive care: a population-wide study of all inhabitants in Stockholm.
    Eur J Epidemiol. 2022;37:157-165.
    PubMed     Abstract available


  42. HVIDE HK, Johnsen J
    COVID-19 and mental health: a longitudinal population study from Norway.
    Eur J Epidemiol. 2022;37:167-172.
    PubMed     Abstract available


    December 2021
  43. COLEMAN T, Sarian A, Grad S
    Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.
    Eur J Epidemiol. 2021;36:1245-1246.
    PubMed    


  44. MULOT M, Segalas C, Leyrat C, Besancon L, et al
    Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.
    Eur J Epidemiol. 2021;36:1243-1244.
    PubMed    


  45. SUBRAMANIAN SV, Kumar A
    The Authors' Reply: Need for a multi-pronged population-level strategy to manage SARS-CoV-2 infection.
    Eur J Epidemiol. 2021;36:1247-1251.
    PubMed    


  46. GIANICOLO E, Wollschlager D, Blettner M
    Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.
    Eur J Epidemiol. 2021;36:1241-1242.
    PubMed    


  47. BJORK J, Modig K, Kahn F, Ahlbom A, et al
    Revival of ecological studies during the COVID-19 pandemic.
    Eur J Epidemiol. 2021;36:1225-1229.
    PubMed    


  48. WOLLSCHLAGER D, Gianicolo E, Blettner M, Hamann R, et al
    Association of COVID-19 mortality with COVID-19 vaccination rates in Rhineland-Palatinate (Germany) from calendar week 1 to 20 in the year 2021: a registry-based analysis.
    Eur J Epidemiol. 2021;36:1231-1236.
    PubMed     Abstract available


  49. SUBRAMANIAN SV, Kumar A
    Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States.
    Eur J Epidemiol. 2021;36:1237-1240.
    PubMed    


    July 2021
  50. ESPENHAIN L, Tribler S, Svaerke Jorgensen C, Holm Hansen C, et al
    Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.
    Eur J Epidemiol. 2021;36:715-725.
    PubMed     Abstract available


  51. BELLUCO S, Mancin M, Marzoli F, Bortolami A, et al
    Prevalence of SARS-CoV-2 RNA on inanimate surfaces: a systematic review and meta-analysis.
    Eur J Epidemiol. 2021;36:685-707.
    PubMed     Abstract available


  52. GOUDSMIT J, van den Biggelaar AHJ, Koudstaal W, Hofman A, et al
    Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program.
    Eur J Epidemiol. 2021;36:753-762.
    PubMed     Abstract available


  53. MCDONALD SA, Miura F, Vos ERA, van Boven M, et al
    Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands.
    Eur J Epidemiol. 2021;36:735-739.
    PubMed     Abstract available


  54. TELLE K, Jorgensen SB, Hart R, Greve-Isdahl M, et al
    Secondary attack rates of COVID-19 in Norwegian families: a nation-wide register-based study.
    Eur J Epidemiol. 2021;36:741-748.
    PubMed     Abstract available


  55. REICHER S, Ratzon R, Ben-Sahar S, Hermoni-Alon S, et al
    Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel.
    Eur J Epidemiol. 2021;36:727-734.
    PubMed     Abstract available


    June 2021
  56. IOANNIDIS JPA
    Over- and under-estimation of COVID-19 deaths.
    Eur J Epidemiol. 2021;36:581-588.
    PubMed     Abstract available


  57. LICHER S, Terzikhan N, Splinter MJ, Velek P, et al
    Design, implementation and initial findings of COVID-19 research in the Rotterdam Study: leveraging existing infrastructure for population-based investigations on an emerging disease.
    Eur J Epidemiol. 2021;36:649-654.
    PubMed     Abstract available


  58. LUNDBERG JO, Zeberg H
    Longitudinal variability in mortality predicts COVID-19 deaths.
    Eur J Epidemiol. 2021;36:599-603.
    PubMed     Abstract available


  59. NAFILYAN V, Islam N, Mathur R, Ayoubkhani D, et al
    Ethnic differences in COVID-19 mortality during the first two waves of the Coronavirus Pandemic: a nationwide cohort study of 29 million adults in England.
    Eur J Epidemiol. 2021;36:605-617.
    PubMed     Abstract available


  60. POZO-MARTIN F, Weishaar H, Cristea F, Hanefeld J, et al
    The impact of non-pharmaceutical interventions on COVID-19 epidemic growth in the 37 OECD member states.
    Eur J Epidemiol. 2021;36:629-640.
    PubMed     Abstract available


  61. FERENCI T
    Different approaches to quantify years of life lost from COVID-19.
    Eur J Epidemiol. 2021;36:589-597.
    PubMed     Abstract available


  62. SCHMITZ T, Meisinger C, Kirchberger I, Thilo C, et al
    Impact of COVID-19 pandemic lockdown on myocardial infarction care.
    Eur J Epidemiol. 2021;36:619-627.
    PubMed     Abstract available


    May 2021
  63. BOTTCHER L, D'Orsogna MR, Chou T
    Using excess deaths and testing statistics to determine COVID-19 mortalities.
    Eur J Epidemiol. 2021;36:545-558.
    PubMed     Abstract available


  64. BATTY GD, Deary IJ, Gale CR
    Pre-pandemic cognitive function and COVID-19 mortality: prospective cohort study.
    Eur J Epidemiol. 2021;36:559-564.
    PubMed     Abstract available


    April 2021
  65. BUSHMAN M, Worby C, Chang HH, Kraemer MUG, et al
    Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China.
    Eur J Epidemiol. 2021;36:429-439.
    PubMed     Abstract available


  66. DE SOUZA FSH, Hojo-Souza NS, da Silva CM, Guidoni DL, et al
    Second wave of COVID-19 in Brazil: younger at higher risk.
    Eur J Epidemiol. 2021;36:441-443.
    PubMed    


    March 2021
  67. BERGMAN J, Ballin M, Nordstrom A, Nordstrom P, et al
    Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study.
    Eur J Epidemiol. 2021;36:287-298.
    PubMed     Abstract available


  68. TERZIKHAN N, Hofman A, Goudsmit J, Ikram MA, et al
    External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population.
    Eur J Epidemiol. 2021;36:319-324.
    PubMed     Abstract available


  69. ELLIOTT J, Bodinier B, Whitaker M, Delpierre C, et al
    COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors.
    Eur J Epidemiol. 2021;36:299-309.
    PubMed     Abstract available


  70. FAN X, Yin C, Wang J, Yang M, et al
    Pre-diagnostic circulating concentrations of insulin-like growth factor-1 and risk of COVID-19 mortality: results from UK Biobank.
    Eur J Epidemiol. 2021;36:311-318.
    PubMed     Abstract available


    February 2021
  71. PEARCE N, Vandenbroucke JP
    Arguments about face masks and Covid-19 reflect broader methodologic debates within medical science.
    Eur J Epidemiol. 2021;36:143-147.
    PubMed     Abstract available


  72. SKJEFTE M, Ngirbabul M, Akeju O, Escudero D, et al
    COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.
    Eur J Epidemiol. 2021;36:197-211.
    PubMed     Abstract available


  73. ACCORSI EK, Qiu X, Rumpler E, Kennedy-Shaffer L, et al
    How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19.
    Eur J Epidemiol. 2021;36:179-196.
    PubMed     Abstract available


  74. CARRAT F, Figoni J, Henny J, Desenclos JC, et al
    Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.
    Eur J Epidemiol. 2021;36:219-222.
    PubMed     Abstract available


  75. GIANICOLO EAL, Russo A, Buchler B, Taylor K, et al
    Gender specific excess mortality in Italy during the COVID-19 pandemic accounting for age.
    Eur J Epidemiol. 2021;36:213-218.
    PubMed     Abstract available


    January 2021
  76. PEARCE N, Moirano G, Maule M, Kogevinas M, et al
    Does death from Covid-19 arise from a multi-step process?
    Eur J Epidemiol. 2021;36:1-9.
    PubMed     Abstract available


    December 2020
  77. LEVIN AT, Hanage WP, Owusu-Boaitey N, Cochran KB, et al
    Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.
    Eur J Epidemiol. 2020;35:1123-1138.
    PubMed     Abstract available


    November 2020
  78. GOMEZ-OCHOA SA, Franco OH
    COVID-19: facts and failures, a tale of two worlds.
    Eur J Epidemiol. 2020;35:991-994.
    PubMed    


  79. CATALANO R, Casey JA, Bruckner TA, Gemmill A, et al
    Non-COVID-19 deaths after social distancing in Norway.
    Eur J Epidemiol. 2020;35:1021-1024.
    PubMed     Abstract available


  80. HANAGE WP, Testa C, Chen JT, Davis L, et al
    COVID-19: US federal accountability for entry, spread, and inequities-lessons for the future.
    Eur J Epidemiol. 2020;35:995-1006.
    PubMed     Abstract available


  81. MILLS EHA, Moller AL, Gnesin F, Zylyftari N, et al
    National all-cause mortality during the COVID-19 pandemic: a Danish registry-based study.
    Eur J Epidemiol. 2020;35:1007-1019.
    PubMed     Abstract available


  82. HUANG J, Teoh JY, Wong SH, Wong MCS, et al
    The potential impact of previous exposure to SARS or MERS on control of the COVID-19 pandemic.
    Eur J Epidemiol. 2020;35:1099-1103.
    PubMed     Abstract available


    June 2020
  83. LIPSITCH M
    Good science is good science: we need specialists, not sects.
    Eur J Epidemiol. 2020;35:519-522.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.